These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 33456721)

  • 21. Advances and Implications in Nanotechnology for Lung Cancer Management.
    Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
    Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects.
    A R; Han Z; Wang T; Zhu M; Zhou M; Sun X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1933. PubMed ID: 37857568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.
    Chan Y; Singh SK; Gulati M; Wadhwa S; Prasher P; Kumar D; Kumar AP; Gupta G; Kuppusamy G; Haghi M; George Oliver BG; Adams J; Chellappan DK; Dua K
    J Drug Deliv Sci Technol; 2022 Aug; 74():103541. PubMed ID: 35774068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology: A promising strategy for the control of parasitic infections.
    AlGabbani Q
    Exp Parasitol; 2023 Jul; 250():108548. PubMed ID: 37196702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology based therapeutics for lung disease.
    Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
    Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary applications and toxicity of engineered nanoparticles.
    Card JW; Zeldin DC; Bonner JC; Nestmann ER
    Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L400-11. PubMed ID: 18641236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New perspectives in nanomedicine.
    Thorley AJ; Tetley TD
    Pharmacol Ther; 2013 Nov; 140(2):176-85. PubMed ID: 23811125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology and tuberculosis: An old disease with new treatment strategies.
    Macêdo DCDS; Cavalcanti IDL; Medeiros SMFRDS; Souza JB; Lira Nogueira MCB; Cavalcanti IMF
    Tuberculosis (Edinb); 2022 Jul; 135():102208. PubMed ID: 35567896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Nanomaterials for Asthma Treatment.
    Zuo X; Guo X; Gu Y; Zheng H; Zhou Z; Wang X; Jiang S; Wang G; Xu C; Wang F
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases.
    Fang Z; Fang J; Gao C; Gao R; Lin P; Yu W
    Drug Deliv; 2022 Dec; 29(1):2805-2814. PubMed ID: 36047245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.
    Huang T; Peng L; Han Y; Wang D; He X; Wang J; Ou C
    Front Immunol; 2022; 13():922301. PubMed ID: 36090974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
    Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
    Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases.
    Dhoundiyal S; Alam MA; Kaur A; Sharma S
    Pharm Nanotechnol; 2023 May; ():. PubMed ID: 37231722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
    Forest V; Pourchez J
    Adv Drug Deliv Rev; 2022 Apr; 183():114173. PubMed ID: 35217112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery.
    Sharma P; Dhanjal DS; Chopra C; Tambuwala MM; Sohal SS; van der Spek PJ; Sharma HS; Satija S
    Chem Biol Interact; 2022 Sep; 365():110050. PubMed ID: 35917947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in nanomaterials for upgrading treatment of orthopedics diseases.
    Shang J; Zhou C; Jiang C; Huang X; Liu Z; Zhang H; Zhao J; Liang W; Zeng B
    Front Bioeng Biotechnol; 2023; 11():1221365. PubMed ID: 37621999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis: A New Horizon of Treatment.
    Lankala CR; Yasir M; Ishak A; Mekhail M; Kalyankar P; Gupta K
    Curr Probl Cardiol; 2023 Jun; 48(6):101671. PubMed ID: 36828044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery.
    Zahin N; Anwar R; Tewari D; Kabir MT; Sajid A; Mathew B; Uddin MS; Aleya L; Abdel-Daim MM
    Environ Sci Pollut Res Int; 2020 Jun; 27(16):19151-19168. PubMed ID: 31079299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.